Therapy News and Research

RSS

Nanoparticles offer new hope for treating red meat allergies linked to tick bites

Nanoparticles delivered intravenously in mice can block the allergic reactions to red meat caused by the bite of the lone star tick, new research led by the University of Michigan shows.

13 Aug 2024

Personalized treatment strategies based on calcification status in breast cancer

Mammographic calcifications, a common feature of breast cancer, have remained enigmatic in terms of their molecular underpinnings and clinical implications, particularly in the hormone receptor-positive, HER2-negative subtype.

13 Aug 2024

McGill discovery offers hope for targeted stem cell treatments

A new technique developed by McGill researchers for mechanically manipulating stem cells could lead to new stem cell treatments, which have yet to fulfill their therapeutic potential.

13 Aug 2024

New insights into the pharmacokinetics of remdesivir in treating SARS-CoV-2 in pregnant women

A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women.

13 Aug 2024

Two studies uncover how immunotherapies work together to activate immune responses in melanoma

Two studies published in the latest issue of the journal Cell by University of Pittsburgh researchers uncover how immunotherapies targeting the immune checkpoints PD1 and LAG3 work together to activate immune responses.

13 Aug 2024

Scientists awarded $7.7 million grant to develop treatment for rare brain disorder

Children born with a damaged gene needed for healthy brain development, SYNGAP1, experience seizures, sensory processing disorders, difficulty speaking, intellectual disability, and autism-like behaviors.

13 Aug 2024

NCI awards $3.1 million to support new mental health model for cancer patients

Depression is common among people with likely incurable cancer – understandably so. But studies have shown that it can be treated, and if the goal is for individuals to be able to engage as much as possible with family, friends, hobbies or whatever gives them joy and purpose in whatever amount of time they have, then treating depression becomes imperative.

13 Aug 2024

Expanding horizons in Parkinson's disease care with non-pharmacological interventions

The field of non-pharmacological interventions for the treatment of individuals with Parkinson's disease (PD) is reaching maturity and has the potential to substantially improve patient care in the future.

13 Aug 2024

Mayo Clinic pioneers use of pulsed field ablation to treat atrial fibrillation

Cardiologists in Mayo Clinic's Heart Rhythm Clinic are using a new innovative energy source to safely and successfully treat a common type of heart arrhythmia.

13 Aug 2024

Early detection of cardiovascular diseases using advanced machine learning

How can diseases of the cardiovascular system be detected before symptoms appear? Researchers at Graz University of Technology (TU Graz) have found a way to track them down at an early stage.

13 Aug 2024

New genomic predictors of relapse in childhood B-cell acute lymphoblastic leukemia uncovered

Scientists from St. Jude Children's Research Hospital, Seattle Children's and the Children's Oncology Group (COG) have identified novel genetic variations that influence relapse risk in children with standard risk B-cell acute lymphoblastic leukemia (SR B-ALL), the most common childhood cancer.

12 Aug 2024

Novel exosome-based drug delivery system for synergistic cancer treatment

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer metastases, leading to a low survival rate for ovarian cancer patients.

12 Aug 2024

Study reveals how light-activated macrophages increase their appetite for cancer cells

The body has a veritable army constantly on guard to keep us safe from microscopic threats from infections to cancer.

12 Aug 2024

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according to new research from The University of Texas MD Anderson Cancer Center.

12 Aug 2024

KERI's transcranial random noise stimulation shows promise for metabolic syndrome treatment

The R&D on neuromodulation technology for the treatment and management of metabolic syndrome conducted by a team led by Dr. Ki-young Shin of Human Care Electro-Medical Device Research Center, Electro-Medical Equipment Research Division of KERI is underway smoothly.

12 Aug 2024

Can a text message program help teens quit vaping?

Study demonstrates that a text message-based program significantly boosts quitting rates among teenage vapers, achieving a 35% higher cessation rate compared to controls.

11 Aug 2024

Calorie restriction and therapy combo reshapes gut microbiome, boosts mental health in women

Study finds that combining caloric restriction with psychological interventions significantly alters the gut microbiome and improves stress-related mental health in women.

11 Aug 2024

New NIH grant supports study on fear of falling in multiple sclerosis

Taylor Takla, a Ph.D. candidate in the translational neuroscience program in Wayne State University's School of Medicine, recently received a two-year, $96,812 F31 grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health to study fear of falling in those with multiple sclerosis (MS).

9 Aug 2024

New insights into retrotransposon-derived DNA zip codes in myeloma cells

A new editorial was published in Oncoscience (Volume 11) on July 13, 2024, entitled, "Unveiling retrotransposon-derived DNA zip code for myeloma cell internalization."

9 Aug 2024

EZH2's role in cancer progression and therapy explored

Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2 (PRC2), which plays a crucial role in transcriptional repression through the methylation of histone H3 on lysine 27 (H3K27me3).

9 Aug 2024

Therapy News and Research

Nanoparticles offer new hope for treating red meat allergies linked to tick bites

Personalized treatment strategies based on calcification status in breast cancer

McGill discovery offers hope for targeted stem cell treatments

New insights into the pharmacokinetics of remdesivir in treating SARS-CoV-2 in pregnant women

Two studies uncover how immunotherapies work together to activate immune responses in melanoma

Scientists awarded $7.7 million grant to develop treatment for rare brain disorder

NCI awards $3.1 million to support new mental health model for cancer patients

Expanding horizons in Parkinson's disease care with non-pharmacological interventions

Mayo Clinic pioneers use of pulsed field ablation to treat atrial fibrillation

Early detection of cardiovascular diseases using advanced machine learning

New genomic predictors of relapse in childhood B-cell acute lymphoblastic leukemia uncovered

Novel exosome-based drug delivery system for synergistic cancer treatment

Study reveals how light-activated macrophages increase their appetite for cancer cells

Engineered NK cells with IL-21 show strong antitumor activity against glioblastoma

KERI's transcranial random noise stimulation shows promise for metabolic syndrome treatment

Can a text message program help teens quit vaping?

Calorie restriction and therapy combo reshapes gut microbiome, boosts mental health in women

New NIH grant supports study on fear of falling in multiple sclerosis

New insights into retrotransposon-derived DNA zip codes in myeloma cells

EZH2's role in cancer progression and therapy explored

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News